Hidradenitis suppurativa is a debilitating, chronic inflammatory disorder where physical examination often fails to capture ...

This guide breaks down how to prepare for an HS appointment so your treatment plan reflects more than just today's flare.

Dermatologists say managing HS-prone skin isn't about harsh products or over-cleansing-it's about reducing irritation and ...

There’s nothing more alarming than finding out your skin has a case of mistaken identity. You go years convinced you have ...

Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive data and initiation of Phase 2 trial during the quarter New immunologic and biomarker data supporting ...

Arcutis Biotherapeutics is evolving into a specialized dermatology platform, leveraging ZORYVE's expanding indications, ...

Achieved positive topline results in Phase 2 LOTUS trial of abdakibart in moderate to severe hidradenitis suppurativa (HS) and plan to advance ...

Detailed price information for Moonlake Immunotherapeutics (MLTX-Q) from The Globe and Mail including charting and trades.

MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the lab ...

MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where ...

(PFE) is running a Phase 2 trial of ritlecitinib in adults with moderate to severe hidradenitis suppurativa, a chronic skin disease that causes painful lumps. The study, officially titled “A Phase 2, ...

Significant improvements as early as Week 1, favorable safety profile and no liver safety concerns in REMIX 1 & 2 studies of ...